- Report
- March 2024
- 190 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Clinical Trials
- August 2020
- 133 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- May 2022
- 36 Pages
Global
From €1946EUR$2,000USD£1,667GBP
Spinal Stenosis Drugs are a type of Central Nervous System (CNS) drug used to treat spinal stenosis, a condition in which the spinal canal narrows and compresses the spinal cord and nerves. These drugs are used to reduce pain, improve mobility, and reduce inflammation. Commonly prescribed drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and muscle relaxants. In some cases, surgery may be recommended to treat spinal stenosis.
The Spinal Stenosis Drug market is a subset of the larger CNS drug market, which includes drugs used to treat a variety of neurological conditions. The market is highly competitive, with many companies offering a range of products. Companies in the market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more